A Quote by John Diamond

A study of over 10,000 patients shows clearly that chemo's supposedly strong track record with Hodgkin's disease (lymphoma) is actually a lie. Patients who underwent chemo were 14 times more likely to develop leukemia and 6 times more likely to develop cancers of the bones, joints, and soft tissues than those patients who did not undergo chemotherapy .
Two to 4% of cancers respond to chemotherapy....The bottom line is for a few kinds of cancer chemo is a life extending procedure-Hodgkin's disease, Acute Lymphocytic Leukemia (ALL), Testicular cancer, and Choriocarcinoma.
In 1978, in the space of 10 months, 28 leukemia patients came to me and they could all work after six days. It is a portal vein circulation disease, not cancer of the blood. So far 150 leukemia patients have come to me and I could help all of them. Do not fear this disease any more.
If there is one lesson that I have learned during my life as an analyst, it is the lesson that what my patients tell me is likely to be true - that many times when I believed that I was right and my patients were wrong, it turned out, though often only after a prolonged search, that my rightness was superficial whereas their rightness was profound.
In 1975, the respected British medical journal Lancet reported on a study which compared the effect on cancer patients of (1) a single chemotherapy, (2) multiple chemotherapy, and (3) no treatment at all. No treatment 'proved a significantly better policy for patients' survival and for quality of remaining life.'
Patients want to be seen as people. For me, the person's life comes first; the disease is simply one aspect of it, which I can guide my patients to use as a redirection in their lives. When doctors look at their patients, however, they are trained to see only the disease.
Whenever you see shrinks on television, they're so clearly written by patients. They're either idealized or they're demonized or they love their patients. All they ever think about is their patients.
The [Tumor Treating Fields] patients can undergo all the activities of their daily life. There's none of the tiredness. There's none of what is called the 'chemo head.'
Black patients were treated much later in their disease process. They were often not given the same kind of pain management that white patients would have gotten and they died more often of diseases.
Lets take away the incentives to do 'to' patients and instead create incentives to do 'for' patients, to be 'with' patients. We don't need to do comparative effectiveness trials to see if that works; we can just ask patients.
Being too happy is bad for you. 8 on 1 10-scale is just right. Eg. cancer patients are more likely to survive if they're at an 8 instead of 9 or 10.
There are several patients - there are thousands of patients, tens of thousands of patients, that carry either a stimulator in the brain or in the periphery, in the inner ear, to restore neurological functions or to control diseases like Parkinson's disease.
I was a very efficient doctor. I would get rewarded with a lot more patients. By the end of my medical career, I had maybe 2,000 patients in my practice.
I will be a role model for cancer patients for the rest of my life. But you know what? When I was getting chemo, those people inspired me.
For most people, chemotherapy is no longer the chamber of horrors we often conceive it to be. Yes, it is an ordeal for some people, but it wasn't for me, nor for most of the patients I got to know during my four months of periodic visits to the chemo suite.
We want combination solutions at the state level, at the local level - whether we've learned from the Chinese about creating what we've been calling COVID wards - creating the ability to actually care for larger numbers of clients and patients in a more concentrated way which allows more oversights so we could really track patients.
Pretty much everybody knows there are not enough organs for all of those patients who need to get transplants, and what happens is, is that organs are actually directed in liver transplantation to those patients who are the sickest. So the patients who have the greatest chance of dying in the next three months or so are the ones who get the priority for the liver transplant.
This site uses cookies to ensure you get the best experience. More info...
Got it!